See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

BioMarin Pharmaceutical (NASDAQ:BMRN) Issues Earnings Results, Beats Estimates By $0.21 EPS

Summary by marketbeat.com
BioMarin Pharmaceutical (NASDAQ:BMRN - Get Free Report) posted its earnings results on Monday. The biotechnology company reported $1.25 earnings per share for the quarter, topping the consensus estimate of $1.02 by $0.23. BioMarin Pharmaceutical had a return on equity of 11.34% and a net margin of 17.76%.

1 Articles

marketbeat.commarketbeat.com
Center

BioMarin Pharmaceutical (NASDAQ:BMRN) Issues Earnings Results, Beats Estimates By $0.21 EPS

BioMarin Pharmaceutical (NASDAQ:BMRN - Get Free Report) posted its earnings results on Monday. The biotechnology company reported $1.25 earnings per share for the quarter, topping the consensus estimate of $1.02 by $0.23. BioMarin Pharmaceutical had a return on equity of 11.34% and a net margin of 17.76%.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

marketbeat.com broke the news in on Tuesday, August 5, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

San Rafael icon

San Rafael

News
For You
SearchBlindspotLocal